PROTAC-Mediated Targeted Protein Degradation | Webinar

Added:

Molecular Glues and Alternative Degradation Modalities

While PROTACs represent a major breakthrough in targeted protein degradation (TPD), they face significant limitations, including high molecular weight (violating Lipinski's Rule of 5), poor oral bioavailability, complex synthesis, and the 'hook effect' (where high concentrations of PROTAC prevent ternary complex formation). Consequently, many researchers argue that 'Molecular Glues' offer a superior alternative. Molecular Glues are smaller, possess better drug-like properties, and exhibit superior cellular permeability. Furthermore, PROTACs are largely restricted to intracellular proteins degraded via the ubiquitin-proteasome system. This has prompted the development of alternative platforms like Lysosome-Targeting Chimeras (LYTACs) and Autophagy-Targeting Chimeras (AUTACs) to target extracellular proteins, aggregates, and non-protein targets, suggesting that the future of TPD lies beyond traditional PROTAC designs.

The Ubiquitin-Proteasome System (UPS): Understanding the cellular machinery responsible for targeted protein degradation, specifically the roles of E1, E2, and E3 ubiquitin ligases.
Medicinal Chemistry Basics: Familiarity with ligand-receptor interactions, binding affinity (Kd), and the concept of occupancy-based drug design vs. event-driven pharmacology.
Protein-Protein Interactions (PPIs): Understanding the structural dynamics of how proteins interact with each other and the thermodynamic principles of ternary complex formation.
Standard Molecular Biology Assays: Knowing how cellular protein levels are measured experimentally, such as through Western blotting, ELISA, or flow cytometry.
Thermodynamics of Ternary Complexes: Analyzing the cooperative binding behavior (alpha factor) and the 'hook effect' (autoinhibition at high PROTAC concentrations).
Molecular Glues vs. PROTACs: Exploring monovalent degraders that remodel protein surfaces to induce degradation, comparing their structural properties to bivalent PROTACs.
DMPK and Rule-of-Five Violations: Investigating the pharmacokinetics and formulation strategies for PROTACs, which typically violate Lipinski's Rule of 5 due to high molecular weight.
Next-Generation Degraders (LYTACs, AUTACs, and DACs): Studying advanced targeted degradation modalities that target extracellular proteins or utilize lysosomal and autophagic pathways.
5.9K views86likes1:14:53@BPSBioscienceSanDiegoOriginal Release: 2021-12-16

PROTACs (Proteolysis-Targeting Chimeras) are bifunctional molecules that hijack the ubiquitin-proteasome system to degrade target proteins by simultaneously binding to the target protein and an E3 ubiquitin ligase, forming a ternary complex that marks the target for proteasomal degradation; successful PROTAC design requires careful consideration of target selection, binder choice, linker length and chemistry, and E3 ligase selection, followed by rigorous experimental validation using techniques such as fluorescence polarization assays, time-resolved FRET, NanoBRET cellular assays, western blotting, and whole-cell proteomics to assess binding affinity, ternary complex formation, cellular engagement, degradation efficacy, and off-target effects.